Hemolytic-uremic syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
Line 54: Line 54:
*[[TAR syndrome|Thrombocytopenia]]
*[[TAR syndrome|Thrombocytopenia]]


Some patients with [[Hemolytic-uremic syndrome|HUS]] may have [[bone marrow]] normal to increased megakaryocytes .
Some patients with [[Hemolytic-uremic syndrome|HUS]] may have [[bone marrow]] normal to increased [[Megakaryocyte|megakaryocytes]] .


==References==
==References==

Revision as of 17:46, 9 August 2018

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome laboratory findings

CDC on Hemolytic-uremic syndrome laboratory findings

Hemolytic-uremic syndrome laboratory findings in the news

Blogs on Hemolytic-uremic syndrome laboratory findings

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

OR

[Test] is usually normal for patients with [disease name].

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

OR

There are no diagnostic laboratory findings associated with [disease name].

Laboratory Findings

An elevated concentration of WBC, thrombocytopenia, normocytic anemia is diagnostic of HUS.[1][2]

Immunohistochemistry among patients with HUS shows reach of VWF.

Laboratory findings consistent with the diagnosis of HUS include:[3]

Some patients with HUS may have bone marrow normal to increased megakaryocytes .

References

  1. Kottke-Marchant, K. (2017). "Diagnostic approach to microangiopathic hemolytic disorders". International Journal of Laboratory Hematology. 39: 69–75. doi:10.1111/ijlh.12671. ISSN 1751-5521.
  2. A. H. Sutor, K. B. Thomas, F. H. Prufer, A. Grohmann, M. Brandis & L. B. Zimmerhackl (2001). "Function of von Willebrand factor in children with diarrhea-associated hemolytic-uremic syndrome (D+ HUS)". Seminars in thrombosis and hemostasis. 27 (3): 287–292. doi:10.1055/s-2001-15267. PMID 11446662. Unknown parameter |month= ignored (help)
  3. J. R. Brandt, L. S. Fouser, S. L. Watkins, I. Zelikovic, P. I. Tarr, V. Nazar-Stewart & E. D. Avner (1994). "Escherichia coli O 157:H7-associated hemolytic-uremic syndrome after ingestion of contaminated hamburgers". The Journal of pediatrics. 125 (4): 519–526. PMID 7931869. Unknown parameter |month= ignored (help)

Template:WH Template:WS